Novacyt new contract win overshadowed by French disappointment
Paris based diagnostics firm Novacyt (NYCT:AIM) said it had received total sales worth £40m as of 1 June and had a further £80m of contracted orders.However, shares dropped 7% to 312p on disappointment that France's public health...
02 June 2020
